Loading provider…
Loading provider…
Radiation Oncology Physician in Iowa City, IA
NPI: 1033470604Primary Practice Location
UNIVERSITY OF IOWA HOSPITAL & CLINICS
200 Hawkins Dr, Iowa City, IA
Primary Employer
University of Iowa Health Care
uihc.org
HQ Phone
Get MD Joseph's Phone Numberphone_androidMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
IA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99205New patient office or other outpatient visit, typically 60 minutes | 85 | 85 |
| 2 | 77300Calculation of radiation therapy dose | 65 | 905 |
| 3 | 77338Design and construction of radiation treatment device for high precision radiation therapy | 50 | 80 |
| 4 | 77301High precision radiation therapy planning | 50 | 80 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 48 | 64 |
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer.
Authors: John Buatti, Naomi Fei, Joseph Cullen, Chandrikha Chandrasekharan, Mandana Kamgar, Daniel Berg
Publication Date: 2024-11
Implementation of a real-time, ultrasound-guided prostate HDR brachytherapy program.
Authors: Smith, Blake R, Strand, Sarah A, Dunkerley, David, Flynn, Ryan T, Besemer, Abigail E, Kos, Jennifer D, Caster, Joseph M, Wagner, Bonnie S, Kim, Yusung
Journal: J Appl Clin Med Phys
Publication Date: 2021-07-26
Lead Sponsor: University of Iowa
Collaborators: GlaxoSmithKline
Intervention / Treatment: DRUG: Niraparib, DRUG: Dostarlimab, RADIATION: Short course radiation
Lead Sponsor: Galera Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Drug GC4711
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Niraparib, RADIATION: Intensity-Modulated Radiation Therapy, BIOLOGICAL: Gonadotrophin Releasing Hormone